The study of the " In Vitro Diagnostics (IVD)
Market" provides the market size information and market trends along with
the factors and parameters impacting it in both short and long term. The study
ensures a 360° view, bringing out the complete key insights of the industry.
The
in–vitro diagnostics(IVD) market in China has been growing rapidly in the past
few years and is expected to grow steadily in the next few years, with major
growth potential in segments such as infectious disease testing, chronic
disease testing and diagnosis in early stages of disease. Some of the major
factors driving the growth of this market are the rising incidences of chronic
lifestyle diseases, public health awareness, growing aging population, demand
of tests in rural areas stimulated by the healthcare reform plan, increasing
demand from the middle class for high–end products and an increase in the
number of private hospitals and independent testing laboratories. However, low
reimbursement rate, absence of quality products by the local companies, population
factors and foreign companies faces difficulty to enter the low end IVD
products market are restraining the growth of this market.
Long–term
Outlook: The China In Vitro Diagnostics Market is expected to reach more than
US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021.
China IVD Market: Segment wise
Outlook
Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.
Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.
China IVD Market: Companies wise
Outlook
Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers to low and mid–end market users.
Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers to low and mid–end market users.
The
research report presents a comprehensive assessment of the market and contains
thoughtful insights, facts, historical data, and statistically supported and
industry–validated market data. It also contains projections using a suitable
set of assumptions and methodologies. The research report provides analysis and
information according to categories such as market, market segments, company
wise sales analysis, regulation, major distributors and laboratories of IVD and
outlook of the Chinese IVD companies.
This report titled “China In
Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and
Market Forecasts to 2021” has been analyzed from 10 viewpoints:
Market and Forecast (2010 – 2021)
Segment Wise Market and Forecast (2010 – 2021)
Company Wise IVD Sales and Forecast (2010 – 2021)
Regulation and its Latest Development
Market and Forecast (2010 – 2021)
Segment Wise Market and Forecast (2010 – 2021)
Company Wise IVD Sales and Forecast (2010 – 2021)
Regulation and its Latest Development
Future Prospects in Attractive In Vitro Diagnostics Segments
Regional Trends and Opportunities
Main Participants/Contributors
Major IVD Product Companies Outlook
Major Private Clinical Labs and Diagnostic Services Companies Outlook
Market Growth Drivers and Challenges
Purchase a copy of China In Vitro
Diagnostics (IVD) Market visit @ http://www.orbisresearch.com/contact/purchase/187419 For more information contact sales@orbisresearch.com .
The following segments of the
China In Vitro Diagnostics market are detailed with size and six year forecast.
Clinical Chemistry
Immunoassay
Molecular Testing
Self–Monitoring of Blood Glucose (SMBG)
Point of Care Testing (POCT)
Hematology
Coagulation
Microbiology
Clinical Chemistry
Immunoassay
Molecular Testing
Self–Monitoring of Blood Glucose (SMBG)
Point of Care Testing (POCT)
Hematology
Coagulation
Microbiology
The following companies of the
China In Vitro Diagnostics market are detailed with size and six year forecast
Roche Diagnostics
Abbott Laboratories
Mindray Medical International Limited
Sysmex Corporation
Shanghai Kehua Bio–Engineering Co. Ltd.
Other Companies
Roche Diagnostics
Abbott Laboratories
Mindray Medical International Limited
Sysmex Corporation
Shanghai Kehua Bio–Engineering Co. Ltd.
Other Companies
The following Chinese companies
of the China In Vitro Diagnostics market are detailed with company overview and
its product portfolio
Mindray Medical International Limited
Shanghai Fosun Pharmaceutical Group
Mingyuan Medicare
Da An Gene Co. Ltd.
Shanghai Kehua Bio–Engineering Co. Ltd.
Zhejiang D.a. Diagnostics Technology Co., Ltd
ADICON Clinical Laboratories
Guangzhou Kingmed Diagnostics Center Co. Ltd.
Kindstar Global
BGI – Shenzhen
OriGene Technologies
Mindray Medical International Limited
Shanghai Fosun Pharmaceutical Group
Mingyuan Medicare
Da An Gene Co. Ltd.
Shanghai Kehua Bio–Engineering Co. Ltd.
Zhejiang D.a. Diagnostics Technology Co., Ltd
ADICON Clinical Laboratories
Guangzhou Kingmed Diagnostics Center Co. Ltd.
Kindstar Global
BGI – Shenzhen
OriGene Technologies
Browse Complete
Report @ http://www.orbisresearch.com/reports/index/china-in-vitro-diagnostics-ivd-opportunity-assessment-competitive-landscape-and-market-forecasts-to-2021 .
Some points from TOC:
1. Executive Summary
2. China In Vitro Diagnostics Market & Forecast (2010 –
2021)
3. China In Vitro Diagnostics Market Share & Forecast
(2010 – 2021)
3.1 China In Vitro Diagnostics Market Share Outlook
3.2 China In Vitro Diagnostics Companies Share Outlook
3.1 China In Vitro Diagnostics Market Share Outlook
3.2 China In Vitro Diagnostics Companies Share Outlook
4. China In Vitro Diagnostics Market – Segment Analysis
(2010 – 2021)
4.1 China Clinical Chemistry Market & Forecast
4.2 China Immunoassay Market & Forecast
4.3 China Molecular Testing Market & Forecast
4.4 China Self–Monitoring of Blood Glucose (SMBG) Market & Forecast
4.5 China Point of Care Testing (POCT) Market & Forecast
4.6 China Hematology Market & Forecast
4.7 China Coagulation Market & Forecast
4.8 China Microbiology Market & Forecast
4.1 China Clinical Chemistry Market & Forecast
4.2 China Immunoassay Market & Forecast
4.3 China Molecular Testing Market & Forecast
4.4 China Self–Monitoring of Blood Glucose (SMBG) Market & Forecast
4.5 China Point of Care Testing (POCT) Market & Forecast
4.6 China Hematology Market & Forecast
4.7 China Coagulation Market & Forecast
4.8 China Microbiology Market & Forecast
5. China In Vitro Diagnostics Market – Company Wise Sales
Analysis (2010 – 2021)
5.1 Roche Diagnostics – China IVD Sales & Forecast
5.2 Abbott Laboratories – China IVD Sales & Forecast
5.3 Mindray Medical International Limited – China IVD Sales & Forecast
5.4 Sysmex Corporation – China IVD Sales & Forecast
5.5 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast
5.6 Other Companies – China IVD Sales & Forecast
5.1 Roche Diagnostics – China IVD Sales & Forecast
5.2 Abbott Laboratories – China IVD Sales & Forecast
5.3 Mindray Medical International Limited – China IVD Sales & Forecast
5.4 Sysmex Corporation – China IVD Sales & Forecast
5.5 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast
5.6 Other Companies – China IVD Sales & Forecast
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter:
https://twitter.com/orbisresearch
Like
us on Facebook: https://www.facebook.com/OrbisResearch
No comments:
Post a Comment